Viemed Healthcare VMD Income Statement (2018-2026)

NASDAQ VMD
$8.61 -0.18 (-1.99%)
As of: Sep 9, 2026 · 1:41 PM EDT
Reported Financials

Viemed Healthcare Quarterly Income Statement

Periods 34 quarters
Latest Jun 2026

Viemed Healthcare reported revenue of $78.10M and net income of $2.90M for the quarter ended Jun 2026, up 23.9% year over year. This income statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
29.29M31.96M32.26M33.31M35.76M37.51M39.56M43.31M49.40M50.74M50.59M54.97M58.00M60.70M59.13M63.06M71.91M76.18M75.41M78.10M
Cost of RevenueCost of Rev
10.90M12.30M12.51M12.92M14.11M14.61M15.55M17.20M18.84M18.63M20.79M22.07M23.63M24.56M25.85M26.32M30.57M32.08M32.59M33.05M
Gross Profit
18.38M19.66M19.74M20.39M21.65M22.90M24.00M26.11M30.56M32.11M29.80M32.89M34.37M36.14M33.28M36.73M41.34M44.10M42.83M45.05M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
2.87M3.12M3.40M3.74M4.12M4.37M4.76M5.21M5.97M
Research & DevelopmentR&D
0.58M0.61M0.63M0.67M0.67M0.72M0.78M0.76M0.59M0.65M0.75M0.76M0.76M0.80M0.80M0.85M0.78M0.60M0.58M0.50M
Selling, General & AdministrativeSG&A
13.26M14.24M15.78M17.54M17.68M17.17M19.76M20.56M23.65M23.91M24.81M26.50M26.67M28.21M28.43M28.80M31.92M32.22M34.79M37.13M
Other Operating ExpensesOther Opex
-0.14M-0.14M0.01M0.11M-0.29M-0.18M0.02M-0.12M-0.28M-0.27M-0.21M0.55M0.47M1.10M2.37M0.64M-0.48M-0.29M-0.36M-0.60M
Operating ExpensesOpex
16.70M17.97M19.80M21.95M22.47M22.27M25.30M26.53M30.22M24.56M25.56M27.26M27.43M29.01M29.22M29.65M32.69M32.82M35.37M37.64M
Operating IncomeOp. Inc
2.92M4.67M2.25M1.00M1.47M3.53M1.93M2.90M4.21M5.29M2.20M3.62M5.63M6.45M3.84M5.09M5.64M8.37M4.30M4.46M
EBIT
2.92M4.67M2.25M1.00M1.47M3.53M1.93M2.90M4.21M5.29M2.20M3.62M5.63M6.45M3.84M5.09M5.64M8.37M4.30M4.46M
Non-operating items
Non Operating Interest Expenses
0.18M0.13M0.30M0.25M
Non Operating Investment IncomeNon-Op. Investment Inc.
-0.20M
Interest & Investment IncomeInt & Inv Inc
-0.07M-0.07M-0.06M-0.06M-0.04M-0.03M0.05M0.02M-0.24M-0.26M-0.15M-0.25M-0.23M-0.15M-0.18M-0.13M-0.51M-0.36M
Other Non Operating IncomeOther Non Op Inc.
0.03M1.50M0.44M0.22M0.11M0.27M0.08M0.00M0.04M-0.03M0.03M-0.56M0.28M0.09M0.07M0.07M0.04M0.06M0.04M0.07M
Net income details
EBT
3.17M5.05M2.51M1.39M1.51M3.58M2.02M3.06M4.24M5.08M2.12M2.25M5.50M6.30M3.66M4.96M5.13M8.01M3.99M4.05M
Tax ProvisionsTaxes
1.39M0.97M0.74M0.42M0.46M1.15M0.50M0.73M1.32M1.60M0.52M0.77M1.59M1.88M0.95M1.71M1.53M2.19M1.30M1.15M
Profit After TaxPAT
1.81M4.14M1.76M0.97M1.17M2.38M1.52M2.33M2.92M3.48M1.60M1.48M3.90M4.42M2.71M3.25M3.60M5.82M2.71M2.90M
Equity Income
0.33M0.46M0.32M0.45M0.08M0.08M0.04M0.14M0.27M0.04M0.07M-1.12M0.10M
Income from Non-Controlling InterestsInc. Minority
0.01M0.03M0.11M0.09M0.09M0.09M0.18M0.13M0.14M
Income from Continuing OperationsIncome (Continuing)
1.79M4.09M1.76M0.97M1.05M2.44M1.52M2.33M2.92M3.48M1.60M1.48M3.90M4.42M2.71M3.25M3.60M5.82M2.69M2.90M
Consolidated Net IncomeConsol Net Inc.
1.79M4.09M1.76M0.97M1.05M2.44M1.52M2.33M2.92M3.48M1.60M1.48M3.90M4.42M2.71M3.25M3.60M5.82M2.69M2.90M
Income towards Parent CompanyParent Net Inc
1.79M4.09M1.76M0.97M1.05M2.44M1.52M2.33M2.92M3.48M1.60M1.48M3.90M4.42M2.71M3.25M3.60M5.82M2.69M2.90M
Net Income towards Common StockholdersNet Income
1.79M4.09M1.76M0.97M1.05M2.44M1.52M2.33M2.92M3.48M1.60M1.48M3.90M4.42M2.71M3.25M3.60M5.82M2.69M2.90M
Additional items
EPS (Basic)
0.050.100.040.020.030.060.040.060.080.090.040.040.100.110.070.080.090.150.070.08
EPS (Diluted)
0.040.100.040.020.030.060.040.060.070.090.040.040.100.110.070.080.090.140.070.07
Shares Outstanding
39.61M39.49M39.62M38.77M38.23M38.66M38.16M38.32M38.44M38.35M38.72M38.82M38.87M38.75M39.43M39.52M38.64M38.90M38.43M38.25M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
40.66M40.68M40.36M39.75M39.58M39.81M40.02M40.68M40.42M40.38M40.58M40.55M40.78M40.81M41.63M41.08M40.50M40.82M40.49M41.13M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
39.63M39.64M39.29M38.22M38.10M38.05M38.28M38.40M38.49M38.51M38.82M38.83M38.93M39.13M39.52M39.61M38.02M38.02M38.53M38.09M
EBITDA
5.79M7.79M5.64M4.74M5.59M7.91M6.70M8.11M10.18M5.29M2.20M3.62M5.63M6.45M3.84M5.09M5.64M8.37M4.30M4.46M
Interest ExpensesInt Expense
0.18M0.13M0.30M0.25M
Tax Rate
43.65%19.15%29.72%30.33%30.18%31.98%24.83%23.81%31.14%31.50%24.42%34.21%28.99%29.83%26.00%34.52%29.89%27.36%32.57%28.41%